About us Contacts Interactions: 118 620
Drug search by name

Gleostine and Myelosuppression

Result of checking the interaction of drug Gleostine and disease Myelosuppression for safety when used together.

Check result:
Gleostine <> Myelosuppression
Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Nitrosoureas induce delayed bone marrow suppression that is cumulative and dose-related. Thrombocytopenia is usually more severe than leukopenia. Anemia occurs less frequently and is less severe. Patients should be instructed to immediately report any signs or symptoms suggesting bone marrow suppression such as fever, sore throat, local infection, bleeding or symptoms of anemia. Therapy with nitrosoureas should be administered cautiously in patients with bone marrow suppression. Blood counts should be monitored at least six weeks after a dose and dosage adjustments made based on the nadir blood counts of the previous dose.

References:
  • "Product Information. BiCNU (carmustine)." Bristol-Myers Squibb, Princeton, NJ.
  • "Product Information. CeeNU (lomustine)." Bristol-Myers Squibb, Princeton, NJ.
Gleostine

Generic Name: lomustine

Brand Name: Gleostine, Ceenu

Synonyms: n.a.

Interaction with food and lifestyle
Drug interactions